BB BIOTECH N (BION.SW) Financials
BION.SW Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 2.6 billion | 304.9 million |
| 2023-09-30 | 2.5 billion | 302.1 million |
| 2023-06-30 | 2.6 billion | 308.5 million |
| 2023-03-31 | 2.6 billion | 315.5 million |
BION.SW Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -928000 | ? |
| 2023-09-30 | 7.4 million | ? |
| 2023-06-30 | 8.7 million | ? |
| 2023-03-31 | 203.1 million | ? |
BION.SW Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 109.1 million |
| 2023-09-30 | -48.4 million |
| 2023-06-30 | -13.5 million |
| 2023-03-31 | -253.9 million |
BION.SW Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 501000 | - | - |
| 2023-09-30 | 322000 | - | - |
| 2023-06-30 | 900000 | - | - |
| 2023-03-31 | 759000 | - | - |
BION.SW Shares Outstanding
BION.SW Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | - | 358000 | 1.6 million |
| 2023-09-30 | - | - | 7.7 million | - |
| 2023-06-30 | - | - | 8.8 million | - |
| 2023-03-31 | - | - | 1.7 million | - |
BION.SW Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 111.2 million | - |
| 2023-09-30 | -40.7 million | 1.7 million |
| 2023-06-30 | -4.7 million | 1.4 million |
| 2023-03-31 | -252.1 million | 1.1 million |
BION.SW
Price: CHF40.45
Dividend Yield: 4.93%
Forward Dividend Yield: 4.79%
Payout Ratio: -116.96%
Dividend Per Share: 2.00 CHF
Earnings Per Share: -1.71 CHF
P/E Ratio: -28.39
Exchange: EBS
Sector: Healthcare
Industry: Biotechnology
Volume: 31889
Market Capitalization: 2.2 billion
Average Dividend Frequency: 1
Years Paying Dividends: 12
DGR3: -7.68%
DGR5: -4.19%
DGR10: 8.56%